Skip to main content
Premium Trial:

Request an Annual Quote

DNAVision Becomes ABI SNPlex Services Provider

NEW YORK (GenomeWeb News) — DNAVision has become an official service provider for Applied Biosystems’ SNPlex genotyping services, the company said today.  
 
Under the agreement, DNAVision, based in Brussels, Belgium, will use the SNPlex platform along with other ABI genotyping and sequencing systems, including Taqman and DNA Analyzers, the company said.
 
DNAVision said it will use the SNPlex system to offer fine mapping, screening, and QTL-analysis projects.
 
Financial terms of the agreement were not released.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.